8 employees
Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.
2020
$31M
from 1 investors over 1 rounds
Sorriso Pharmaceuticals raised $31M on December 22, 2021
Investors: Arix Bioscience plc